Vera Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| AVORO CAPITAL ADVISORS LLC | 02/14/2025 | 5.61 M | $237.25 M | 30.17% | 10.22% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 4.38 M | $185.11 M | 11.12% | 7.97% |
| BLACKROCK, INC. | 02/07/2025 | 3.94 M | $166.69 M | 14.17% | 7.18% |
| FMR LLC | 02/13/2025 | 3.05 M | $129.12 M | 9.62% | 5.56% |
| VANGUARD GROUP INC | 02/11/2025 | 2.95 M | $124.74 M | 14.32% | 5.37% |
| SOFINNOVA INVESTMENTS, INC. | 02/14/2025 | 2.79 M | $118.16 M | 0.00% | 5.09% |
| STATE STREET CORP | 02/14/2025 | 2.03 M | $85.69 M | 11.11% | 3.69% |
| COMMODORE CAPITAL LP | 02/14/2025 | 1.96 M | $82.83 M | -20.86% | 3.57% |
| HOLOCENE ADVISORS, LP | 02/14/2025 | 1.88 M | $79.33 M | -4.02% | 3.42% |
| SAMLYN CAPITAL, LLC | 02/14/2025 | 1.66 M | $70.30 M | 22.29% | 3.03% |
| EVERSEPT PARTNERS, LP | 02/14/2025 | 1.60 M | $67.66 M | -21.96% | 2.91% |
| KYNAM CAPITAL MANAGEMENT, LP | 02/14/2025 | 1.46 M | $61.66 M | -7.53% | 2.66% |
| PARADIGM BIOCAPITAL ADVISORS LP | 02/14/2025 | 1.44 M | $60.79 M | 31.04% | 2.62% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 02/14/2025 | 1.42 M | $59.85 M | 43.82% | 2.58% |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 02/14/2025 | 1.26 M | $53.34 M | 78.84% | 2.30% |
| WOODLINE PARTNERS LP | 02/14/2025 | 1.20 M | $50.85 M | 20.14% | 2.19% |
| LORD, ABBETT & CO. LLC | 02/14/2025 | 1.15 M | $48.79 M | 170.81% | 2.10% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 1.15 M | $48.79 M | 14.80% | 2.10% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 02/14/2025 | 1.15 M | $48.63 M | 130.00% | 2.09% |
| FEDERATED HERMES, INC. | 02/13/2025 | 1.09 M | $45.93 M | 162.25% | 1.98% |
| VESTAL POINT CAPITAL, LP | 02/14/2025 | 1.08 M | $45.46 M | 100.00% | 1.96% |
| LOGOS GLOBAL MANAGEMENT LP | 02/14/2025 | 875,000 | $37.00 M | 75.00% | 1.59% |
| PICTET ASSET MANAGEMENT HOLDING SA | 02/12/2025 | 841,313 | $35.58 M | 47.08% | 1.53% |
| MARSHALL WACE, LLP | 02/13/2025 | 837,146 | $35.40 M | 43.41% | 1.52% |
| JENNISON ASSOCIATES LLC | 01/24/2025 | 813,861 | $34.42 M | 82.03% | 1.48% |
| DEUTSCHE BANK AG\ | 02/14/2025 | 810,376 | $34.27 M | 5.72% | 1.48% |
| SIREN, L.L.C. | 02/14/2025 | 758,465 | $32.08 M | -9.48% | 1.38% |
| ORBIMED ADVISORS LLC | 02/14/2025 | 742,572 | $31.40 M | 9.87% | 1.35% |
| VOYA INVESTMENT MANAGEMENT LLC | 02/14/2025 | 695,091 | $29.40 M | 572.18% | 1.27% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 554,729 | $23.46 M | -7.52% | 1.01% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 02/14/2025 | 487,863 | $20.63 M | 27.22% | 0.89% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 02/12/2025 | 485,145 | $20.41 M | 1.77% | 0.88% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2025 | 480,000 | $20.30 M | -65.07% | 0.87% |
| FIRST TURN MANAGEMENT, LLC | 02/14/2025 | 464,807 | $19.66 M | 42.36% | 0.85% |
| NORTHERN TRUST CORP | 02/14/2025 | 455,007 | $19.24 M | 24.56% | 0.83% |
| ALTIUM CAPITAL MANAGEMENT LP | 02/13/2025 | 432,000 | $18.27 M | -36.84% | 0.79% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 430,665 | $18.21 M | 19.03% | 0.78% |
| AMERICAN CENTURY COMPANIES INC | 02/11/2025 | 428,940 | $18.14 M | 11.01% | 0.78% |
| AFFINITY ASSET ADVISORS, LLC | 02/13/2025 | 425,000 | $17.97 M | -2.30% | 0.77% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/14/2025 | 385,425 | $16.30 M | 119.50% | 0.70% |
| CANDRIAM S.C.A. | 02/07/2025 | 365,999 | $15.48 M | -18.85% | 0.67% |
| MORGAN STANLEY | 02/14/2025 | 328,515 | $13.89 M | -3.68% | 0.60% |
| BIOIMPACT CAPITAL LLC | 02/14/2025 | 257,788 | $10.90 M | 100.00% | 0.47% |
| AXA S.A. | 02/14/2025 | 245,879 | $10.40 M | -0.16% | 0.45% |
| ALPHABET INC. | 02/07/2025 | 241,264 | $10.20 M | 0.00% | 0.44% |
| VICTORY CAPITAL MANAGEMENT INC | 02/06/2025 | 235,267 | $9.95 M | 515.03% | 0.43% |
| TD ASSET MANAGEMENT INC | 02/11/2025 | 230,558 | $9.75 M | 19.53% | 0.42% |
| JPMORGAN CHASE & CO | 02/12/2025 | 221,485 | $9.37 M | 71.57% | 0.40% |
| CUTTER CAPITAL MANAGEMENT, LP | 02/14/2025 | 212,696 | $8.99 M | 23.03% | 0.39% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/14/2025 | 194,027 | $8.21 M | 13.09% | 0.35% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Vera Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 208 institutional investors and hedge funds held shares of Vera Therapeutics, Inc.. The most heavily invested institutionals were:
Avoro Capital Advisors LLC: 5.61 M
PRICE T ROWE ASSOCIATES INC /MD/: 4.38 M
BlackRock, Inc.: 3.94 M
FMR LLC: 3.05 M
VANGUARD GROUP INC: 2.95 M
Sofinnova Investments, Inc.: 2.79 M
114.60% of Vera Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 72.34 M shares in the last 24 months. This purchase volume represents approximately $1.54 B in transactions.